Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

TAWBI, HUSSEIN

One or more keywords matched the following items that are connected to TAWBI, HUSSEIN

Item Type	Name
Concept	Melanoma
Concept	Melanoma, Experimental
Academic Article	Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial.
Academic Article	Does pegylated interferon Î±-2b confer additional benefit in the adjuvant treatment of high-risk melanoma?
Academic Article	Ligand-Independent EPHA2 signaling drives the adoption of a targeted Therapy-Mediated metastatic melanoma phenotype
Academic Article	Melanoma central nervous system metastases
Academic Article	MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxelbased therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603
Academic Article	RAF kinase inhibitors for the treatment of melanoma
Academic Article	Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma
Academic Article	Selective BRAF inhibitors make inroads in mutated metastatic melanoma
Academic Article	Targeted therapy in melanoma
Academic Article	Immune Checkpoint Inhibitor Therapy in a Liver Transplant Recipient With Melanoma.
Academic Article	Management of metastatic melanoma.
Academic Article	Safety and efficacy of arsenic trioxide for patients with advanced metastatic melanoma.
Academic Article	Does pegylated interferon alpha-2b confer additional benefit in the adjuvant treatment of high-risk melanoma?
Academic Article	Targeted therapy in melanoma.
Academic Article	Chemotherapy resistance abrogation in metastatic melanoma.
Academic Article	Safety and efficacy of combination immunotherapy with interferon alfa-2b and tremelimumab in patients with stage IV melanoma.
Academic Article	A potential role for nilotinib in KIT-mutated melanoma.
Academic Article	Targeted therapies: BREAKing a path for progress--dabrafenib confirms class effect.
Academic Article	PD-1 and Tim-3 regulate the expansion of tumor antigen-specific CD8? T cells induced by melanoma vaccines.
Academic Article	Melanoma brain metastases: an unmet challenge in the era of active therapy.
Academic Article	Selective BRAF inhibitors make inroads in mutated metastatic melanoma.
Academic Article	Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab.
Academic Article	Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma.
Academic Article	Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype.
Academic Article	Matching wits with melanoma brain metastases: from biology to therapeutics.
Academic Article	MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxel-based therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603.
Academic Article	Combination therapies for treating metastatic melanoma.
Academic Article	MicroRNA-125a promotes resistance to BRAF inhibitors through suppression of the intrinsic apoptotic pathway.
Academic Article	Melanoma Brain Metastases: Current Areas of Investigation and Future Directions.
Academic Article	Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma.
Academic Article	Safe and effective administration of T-VEC in a patient with heart transplantation and recurrent locally advanced melanoma.
Academic Article	Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600E.
Academic Article	High-dose interleukin-2 (HD IL-2) for advanced melanoma: a single center experience from the University of Pittsburgh Cancer Institute.
Academic Article	Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.
Academic Article	Evaluation of Biodistribution of Sulforaphane after Administration of Oral Broccoli Sprout Extract in Melanoma Patients with Multiple Atypical Nevi.
Academic Article	Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2.
Academic Article	Targeted Therapy and Immunotherapy Response Assessment with F-18 Fluorothymidine Positron-Emission Tomography/Magnetic Resonance Imaging in Melanoma Brain Metastasis: A Pilot Study.
Academic Article	Metastatic melanoma with balloon/histiocytoid cytomorphology after treatment with immunotherapy: A histologic mimic and diagnostic pitfall.
Academic Article	Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome.
Academic Article	Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
Academic Article	Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
Academic Article	Vaccine therapy + dasatinib for the treatment of patients with stage IIIB-IV melanoma.
Academic Article	New Era in the Management of Melanoma Brain Metastases.
Academic Article	Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.
Academic Article	Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities.
Academic Article	Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Academic Article	NCI 8628: A randomized phase 2 study of ziv-aflibercept and high-dose interleukin 2 or high-dose interleukin 2 alone for inoperable stage III or IV melanoma.
Academic Article	Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Academic Article	Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Academic Article	Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).
Academic Article	Reply to A. Shinde et al.
Academic Article	PARP1 rs1805407 Increases Sensitivity to PARP1 Inhibitors in Cancer Cells Suggesting an Improved Therapeutic Strategy.
Academic Article	Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases.
Academic Article	Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma.
Academic Article	Multiple antigen-engineered DC vaccines with or without IFNa to promote antitumor immunity in melanoma.
Academic Article	The great debate at "Melanoma Bridge 2018", Naples, December 1st, 2018.
Academic Article	Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients.
Academic Article	Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium.
Academic Article	Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3K? Inhibition in PTEN Loss Melanoma.
Academic Article	Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma.
Academic Article	Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series.
Academic Article	A promising start for checkpoint inhibitors in childhood malignancies.
Academic Article	Leptomeningeal disease in melanoma patients: An update to treatment, challenges, and future directions.
Academic Article	B cells and tertiary lymphoid structures promote immunotherapy response.
Academic Article	Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma.
Academic Article	Circulating Tumor Cells and Early Relapse in Node-positive Melanoma.
Academic Article	"Liquid Gold" - The unTAPped Potential of Cerebrospinal Fluid Analysis?
Academic Article	The standard of care for brain metastases in melanoma.
Academic Article	Calcium-sensing receptor autoantibody-mediated hypoparathyroidism associated with immune checkpoint inhibitor therapy: diagnosis and long-term follow-up.
Academic Article	Bullous Pemphigoid-like Eruption Triggered by Targeted Therapy for Metastatic Melanoma.
Academic Article	Molecular and immunological associations of elevated serum lactate dehydrogenase in metastatic melanoma patients: A fresh look at an old biomarker.
Academic Article	Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i.
Academic Article	The State of Melanoma: Emergent Challenges and Opportunities.
Academic Article	Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).
Academic Article	The efficacy of anti-programmed cell death protein 1 therapy among patients with metastatic acral and metastatic mucosal melanoma.
Academic Article	The "Great Debate" at Melanoma Bridge 2020: December, 5th, 2020.
Academic Article	A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma.
Academic Article	Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204).
Academic Article	Nonsurgical Management of Melanoma Brain Metastasis: Current Therapeutics, Challenges, and Strategies for Progress.
Academic Article	Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma.
Academic Article	Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade.
Academic Article	Acute motor axonal neuropathy after ipilimumab and nivolumab treatment in melanoma brain metastases: A case report and review of the literature.
Academic Article	Identification of MicroRNA-mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes.
Academic Article	Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study.
Academic Article	Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf-mutated melanoma.
Academic Article	Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma.
Academic Article	Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefit.
Academic Article	Treatment patterns and clinical outcomes for patients with melanoma and central nervous system metastases: A real-world study.
Academic Article	Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.
Academic Article	Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.
Academic Article	Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600-Mutant Unresectable or Metastatic Melanoma.
Academic Article	Nivolumab plus ipilimumab in melanoma brain metastases - Authors' reply.
Academic Article	Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma.
Academic Article	Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).
Academic Article	Economic and health care resource utilization burden of central nervous system metastases in patients with metastatic melanoma.
Academic Article	Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses.
Academic Article	Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).
Academic Article	The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021.
Academic Article	Nivolumab with or without Relatlimab in Untreated Advanced Melanoma. Reply.
Academic Article	Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
Academic Article	Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with BRAF V600-mutant melanoma: exploratory biomarker analyses from a randomized phase 3 trial (COMBI-i).
Academic Article	Symptomatic melanoma CNS metastases in the TRICOTEL study - Authors' reply.
Academic Article	Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases.
Academic Article	Neoadjuvant relatlimab and nivolumab in resectable melanoma.
Academic Article	Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study.
Academic Article	Current and emerging options for patients with melanoma brain metastases.
Academic Article	Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma.
Academic Article	Resistance to anti-PD1 therapies in patients with advanced melanoma: systematic literature review and application of the Society for Immunotherapy of Cancer Immunotherapy Resistance Taskforce anti-PD1 resistance definitions.
Academic Article	Changes in outcomes and factors associated with survival in melanoma patients with brain metastases.
Academic Article	Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities.
Academic Article	Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial.
Academic Article	Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma.
Academic Article	Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with targeted therapies.
Academic Article	Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results.
Academic Article	Trametinib in Patients With NF1-, GNAQ-, or GNA11-Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2.
Academic Article	The "Great Debate" at Melanoma Bridge 2022, Naples, December 1st-3rd, 2022.
Academic Article	Neoadjuvant immunotherapy for melanoma is now ready for clinical practice.
Academic Article	Health-related quality of life with nivolumab plus relatlimab versus nivolumab monotherapy in patients with previously untreated unresectable or metastatic melanoma: RELATIVITY-047 trial.
Academic Article	Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study.
Academic Article	The introduction of LAG-3 checkpoint blockade in melanoma: immunotherapy landscape beyond PD-1 and CTLA-4 inhibition.
Academic Article	Gut Microbiome in Patients With Early-Stage and Late-Stage Melanoma.
Academic Article	Treatment experience with encorafenib plus binimetinib for BRAF V600-mutant metastatic melanoma: management insights for clinical practice.
Academic Article	Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0.
Academic Article	Real-world outcomes with immuno-oncology therapies in advanced melanoma: final results of the OPTIMIzE registry study.
Academic Article	The Symptom Experience of Patients with Advanced Melanoma Undergoing Immune Checkpoint Inhibitor (ICI) Therapy.
Academic Article	Overall Survival and Response with Nivolumab and Relatlimab in Advanced Melanoma.
Academic Article	Local and Systemic Management Options for Melanoma Brain Metastases.
Academic Article	Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity.

Search Criteria

Melanoma